Opening doors to new medicines.
Location: United States, California, San Diego
Employees: 51-200
Total raised: $225M
Founded date: 2018
Investors 8
| Date | Name | Website |
| 08.11.2022 | M Ventures | m-ventures... |
| - | DCVC | dcvc.com/ |
| 10.08.2025 | aMoon Fund | amoon.fund... |
| - | The Column... | thecolumng... |
| 22.01.2021 | Lux Capita... | luxcapital... |
| - | TCG Crosso... | tcgcrossov... |
| - | Neotribe V... | neotribe.v... |
| - | NFLS - Piv... | pivotalbio... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 28.08.2025 | - | $60M | - |
| 28.02.2022 | - | $102M | - |
| 25.01.2021 | Series A | $35M | - |
| 22.10.2019 | Series A | $28M | - |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Swaroop 'K... | Kolluri | Board Obse... | linkedin.c... | - | - |
Mentions in press and media 19
| Date | Title | Description |
| 28.08.2025 | Months after layoffs, AbbVie-partnered protein degrader specialist Plexium raises $60M | Plexium has raised $60.1 million, providing an infusion of cash for the recently slimmed-down protein degrader specialist three years on from its breakout year. The biotech put itself on the map in 2022 by securing a deal with Amgen worth u... |
| 28.02.2022 | Plexium Raises $102M Financing | Plexium, a San Diego, CA-based targeted protein degradation (TPD) company, raised $102M in funding. The round was led by BVF Partners, L.P. and TCG X, with participation from Softbank Vision Fund 2, RA Capital Management, Surveyor Capital, ... |
| 23.02.2022 | Plexium Announces $102M Financing | - |
| 23.02.2022 | Plexium acquires $102M of growth funding to accelerate growth of pipeline programs | - |
| 23.02.2022 | Plexium nabs $102M for protein degradation work weeks after $500M Amgen tie-up | Just weeks after inking a $500 million biobucks pact with Amgen, protein degradation biotech Plexium has secured $102 million in venture capital funds. The preclinical biotech raised the funds to bankroll work on protein degraders for an im... |
| 25.01.2021 | Plexium Announces $35m Financing to Advance Pipeline of Novel Protein Degraders | Plexium Announces $35m Financing to Advance Pipeline of Novel Protein Degraders Company also announces appointment of biotech veteran Mike Grey as Chairman of the Board |
| 21.01.2021 | Plexium Finds $35M More For Biotech Efforts | San Diego-based Plexium, a biotech startup focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug targets, announced this morning that it has raised $35M in a financing round. The... |
| 21.01.2021 | Plexium Raises $35M in Funding | Plexium, Inc., a San Diego, CA-based biotech company focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug targets, completed a $35M financing. The round was led by Lux Capital a... |
| 21.01.2021 | Plexium has announced raising an additional $35M to their Series A round, bringing the total funding for the round to $63M | - |
| 21.01.2021 | Plexium Announces $35M Series A Extension | SAN DIEGO, CA, Plexium has completed a $35 million financing round. >> Click here for more funding data on Plexium >> To export Plexium funding data to PDF and Excel, click here Plexium, a biotech company focused on disco... |
Show more